Retatrutide, however, wont be on the market until it completes Phase 3 and earns FDA approval
Preclinical studies in rodent models have consistently demonstrated that GLP-1 receptor agonists reduce voluntary alcohol intake and preference
We numb the insertion site with local anesthetic before placing the pellets, so the procedure itself is virtually painless
According to a study published at the end of October in the journal Alzheimers & Dementia , semaglutidewhich started out as a type 2 diabetes drug before transforming into weight loss superstar drugs sold under brand names like Ozempic, Wegovy and Rybelsusmay reduce peoples risk of Alzheimers disease
Right now, people who are prescribed GLP-1s have some kind of risk factor for Alzheimers, whether its being overweight, obesity, or type 2 diabetes
Anti-Obesity Drugs Are Closing the Gap Between Dieting and Bariatric Surgery